14 completed, 7 unknown, 4 terminated, 2 recruiting. 28 Phase 2, 4 Phase 1, 4 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 28 | Completed 14, Unknown 7, Terminated 4, Recruiting 2, Not yet recruiting 1 |
| Phase 1 | 4 | Unknown 4 |
| Phase 3 | 4 | Completed 2, Not yet recruiting 1, Unknown 1 |
Follow Deferoxamine: new trials by email Literature Review of Deferoxamine trials Research Report on Deferoxamine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Synergistic Minimally Invasive Surgery and Deferoxamine in ICH Minimally Invasive surgery (MIS), Deferoxamine, Standard Medical Care (SMD) - Intracerebral Hemorrhage, ICH - Intracerebral Hemorrhage | Phase 2 / Phase 3 | Not yet recruiting | University of Illinois at Chicago | 240 | 2026-03-01 | 2025-10-10 |
| Early Screening and Treatment of Heart Complication in Sickle Cell Disease Deferoxamine, Deferasirox, Deferiprone - Sickle Cell Disease | Phase 2 | Recruiting | Inova Health Care Services | 100 | 2025-10-07 | 2026-09-09 |
| Effect of Deferoxamine on Wound Healing Rate in Patients With Diabetes Foot Ulcers Deferoxamine, Placebo - Diabetic Foot Ulcer | Phase 2 | Unknown | Karolinska University Hospital | 174 | 2022-12-30 | 2022-05-26 |
| Deferoxamine in Aneurysmal Subarachnoid Hemorrhage Trial Deferoxamine, placebo - Intracranial Aneurysm, Subarachnoid Hemorrhage | Phase 1 / Phase 2 | Unknown | Radboud University Medical Center | 40 | 2022-12-02 | 2023-04-24 |
| Deferoxamine Plus Chemotherapy for Metastatic Triple Negative Breast Cancer Deferoxamine Plus Chemotherapy - Triple Negative Breast Cancer | Phase 2 | Terminated | Sun Yat-sen University | 25 | 2022-03-21 | 2025-07-22 |
| Deferoxamine In the Treatment of Aneurysmal Subarachnoid Hemorrhage (aSAH) Deferoxamine, Placebo - Aneurysmal Subarachnoid Hemorrhage | Phase 2 | Recruiting | Aditya S. Pandey, MD | 120 | 2022-03-20 | 2026-11-12 |
| Deferoxamine for the Prevention of Cardiac Surgery-Associated Acute Kidney Injury Deferoxamine, Normal saline - Acute Kidney Injury | Phase 2 | Completed | Brigham and Women's Hospital | 320 | 2021-04-13 | 2026-10-06 |
| Application of Desferal to Treat COVID-19 Deferoxamine - COVID-19 | Phase 1 / Phase 2 | Unknown | Kermanshah University of Medical Sciences | 50 | 2020-04-01 | 2020-05-04 |
| Hydroxy Urea, Omega 3, Nigella Sativa,Honey on Oxidative Stress and Iron Chelation in Pediatric Major Thalassemia Omega 3, Nigella Sativa Oil, Hydroxyurea - Iron Overload, Oxidative Stress | Phase 2 / Phase 3 | Completed | Beni-Suef University | 350 | 2019-11-01 | 2021-01-27 |
| Desferal Administration to Improve the Impaired Reaction to Hypoxia in Diabetes desferal, Isotonic saline - Diabetes Mellitus, Type 1 | Phase 2 | Unknown | Karolinska University Hospital | 30 | 2017-01-01 | 2022-05-26 |
| Deferoxamine and Xingnaojing Injection Treatment in Intracerebral Hemorrhage deferoxamine, Xingnaojing injection, Normal saline - Intracerebral Hemorrhage | Phase 1 / Phase 2 | Unknown | Capital Medical University | 180 | 2015-03-01 | 2015-05-18 |
| Intracerebral Hemorrhage Deferoxamine Trial - iDEF Ttrial Deferoxamine Mesylate, Placebo (for Deferoxamine Mesylate) - Intracerebral Hemorrhage | Phase 2 | Completed | Beth Israel Deaconess Medical Center | 294 | 2014-10-01 | 2019-05-30 |
| Amlodipine for Myocardial Iron in Thalassemia Standard Chelation, Amlodipine - Thalassemia | Phase 2 / Phase 3 | Completed | Aga Khan University | 20 | 2014-02-01 | 2017-06-29 |
| High-Dose Deferoxamine in Intracerebral Hemorrhage Deferoxamine, Normal saline - Intracerebral Hemorrhage | Phase 2 | Terminated | Beth Israel Deaconess Medical Center | 42 | 2013-03-18 | 2019-06-12 |
| Study Of Efficacy,Safety of Combined Deferasirox and Deferiprone Versus Combined Deferiprone and Desferal In Conditions of Iron Overload DFP (ferriprox) and deferasirox (ICL 670), DFP, DFO - Beta-thalassemia Major, Sickle Cell Disease | Phase 2 / Phase 3 | Unknown | Ain Shams University | 60 | 2012-02-01 | 2012-02-06 |
| Efficacy and Safety of Deferasirox in Combination With Deferoxamine Followed by Deferasirox Monotherapy in Severe Cardiac Iron Overload Deferasirox and Deferoxamine - Cardiac Iron Overload | Phase 2 | Completed | Novartis Pharmaceuticals | 60 | 2011-01-01 | 2021-07-26 |
| Safety and Efficacy of Deferasirox in Combination With Desferoxamine in β-thalassaemia Patients With Severe Cardiac Iron Overload Deferasirox, Deferoxamine (DFO) - Transfusion-dependent β-thalassemia Patients, Cardiac Iron Overload | Phase 2 | Terminated | Novartis Pharmaceuticals | 32 | 2011-01-01 | 2019-10-23 |
| N-acetylcysteine Plus Deferoxamine for Patients With Hypotension N-acetylcysteine and deferoxamine - Hypotension, Acute Renal Failure | Phase 2 | Completed | Universidade do Extremo Sul Catarinense - Unidade Academica de Ciecias da Saude | 81 | 2009-03-01 | 2015-05-28 |
| Thrombolysis and Deferoxamine in Middle Cerebral Artery Occlusion Deferoxamine - Ischemic Stroke, Acute | Phase 2 | Completed | Germans Trias i Pujol Hospital | 62 | 2008-09-01 | 2022-08-08 |
| Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both Deferoxamine, Deferasirox - Thalassemia | Phase 1 / Phase 2 | Unknown | Weill Medical College of Cornell University | 6 | 2008-08-01 | 2010-11-05 |
Showing 20 of 28. Sign in to see all of them.
Iron Overload (9) · Thalassemia (6) · Anemia, Sickle Cell (4) · Cerebral Hemorrhage (4) · beta-Thalassemia (4) · Hemochromatosis (3) · Intracranial Hemorrhages (3) · Acute Kidney Injury (2) · Myelodysplastic Syndromes (2) · Stroke (2) · Subarachnoid Hemorrhage (2) · Anemia (1) · Anemia, Diamond-Blackfan (1) · Anemia, Hemolytic (1) · Anemia, Sideroblastic (1)
Novartis Pharmaceuticals (6) · Beth Israel Deaconess Medical Center (2) · Karolinska University Hospital (2) · Aditya S. Pandey, MD (1) · Aga Khan University (1) · Ain Shams University (1) · Beni-Suef University (1) · Brigham and Women's Hospital (1) · Capital Medical University (1) · Carelon Research (1) · Elliott Vichinsky (1) · Germans Trias i Pujol Hospital (1) · Inova Health Care Services (1) · Kermanshah University of Medical Sciences (1) · Lipomed (1)
United States (12) · Canada (6) · Egypt (4) · China (3) · Greece (2) · Italy (2) · Taiwan (2) · Thailand (2) · Turkey (Türkiye) (2) · United Kingdom (2) · Brazil (1) · Cyprus (1) · Iran (1) · Lebanon (1) · Netherlands (1)
Magdy Selim, MD, PhD (2) · Aditya Pandey, MD (1) · Ahmed F Mahmoud Hussein, MS.c (1) · Amir Kiani, PhD (1) · Babar Hasan (1) · David E. Leaf, MD, MMSc (1) · Elliot Vichinsky, MD (1) · Elliott P, Vichinsky, MD (1) · Ellis J. Neufeld, MD (1) · Gursant S. Atwal, MD (1) · Javed Iqbal, MBBS (1) · Jeroen Boogaarts, M.D., Ph.D. (1)
PMID 33236783, PMID 37975597, PMID 10051178, PMID 10669330, PMID 11886437, PMID 1406879, PMID 16787239, PMID 17233848, PMID 18369153, PMID 18552864, PMID 22045831, PMID 22187937, PMID 22547607, PMID 2265118, PMID 22875626, PMID 23151373, PMID 23943316, PMID 24385534, PMID 25076907, PMID 25291189, PMID 25345697, PMID 25492271, PMID 25600572, PMID 25934475, PMID 27745551, PMID 28583206, PMID 29619244, PMID 29719970, PMID 30898550, PMID 33758069, PMID 34439518, PMID 34789008, PMID 35306827, PMID 35676589, PMID 38689404, PMID 38979830, PMID 40399657, PMID 40418029, PMID 40789806, PMID 7811060, PMID 8067783, PMID 8554902, PMID 8665150, PMID 9633879
U01NS074425 (2), 2009 (1), R01DK125786 (1), U01HL065232 (1), U01HL065238 (1), U01HL065239 (1), U01HL065244 (1), U01HL065260 (1)